The prediction of lateral lymph node metastasis using One Step Nucleic Acid Amplification method in the rectal cancer

The prediction of lateral lymph node metastasis using One Step Nucleic Acid Amplification method in the rectal cancer - The prediction of lateral lymph node metastasis using OSNA method in the rectal cancer

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000031964

Enrollment

Registered

2018-03-29

Start date

2018-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Locally advanced lower rectal cancer undergoing mesorectal excision and lateral lymoh node dissection

Exclusion criteria

Exclusion criteria: Neoadjuvant therapy

Design outcomes

Primary

Measure	Time frame
The negative predictive value of mesorectal OSNA diagnosis for pathological lateral lymph node metastasis	—

Countries

Japan

Contacts

Public ContactMasakatsu Numata

Yokohama City University Department of Surgery

numata@yokohama-cu.ac.jp045-787-2645

Outcome results